In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Indoxen Drug Master File in Korea (Indoxen KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Indoxen. The MFDS reviews the Indoxen KDMF as part of the drug registration process and uses the information provided in the Indoxen KDMF to evaluate the safety and efficacy of the drug.
After submitting a Indoxen KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Indoxen API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Indoxen suppliers with KDMF on PharmaCompass.